Results 321 to 330 of about 436,571 (380)

(MU-CTL-01-14) SimSYS Game Specification [PDF]

open access: yes, 2014
Cooper, Kendra   +3 more
core   +1 more source

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

open access: yesCancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu   +4 more
wiley   +1 more source

CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer

open access: yesCancer Communications, EarlyView.
Abstract Background Third‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) show initial efficacy in EGFR‐mutated lung cancer, but residual disease persists. This study aimed to investigate cluster of differentiation 24 (CD24) as a translational immunotherapeutic target for enhancing third‐generation EGFR‐TKI efficacy.
Jiaqi Liang   +16 more
wiley   +1 more source

Efficacy of Essential Oil of Algrizea minor Sobral, Faria & Proença (Myrtaceae) in Combating Methicillin‐resistant Staphylococcus aureus: Antibacterial and Virulence Modulation Studies Conducted In Vitro and In Vivo

open access: yesChemistry &Biodiversity, EarlyView.
This study explored the antibacterial, antivirulence, and in vivo effects of Algrizea minor essential oil (EOAM), against MRSA isolates. Chemical analysis by GC‐MS has been performed. The oil exhibited synergistic effects when combined with amoxicillin and oxacillin, inhibiting biofilm formation and reducing S. aureus‐induced hemolysis.
Amanda Vieira de Barros   +14 more
wiley   +1 more source

Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells. [PDF]

open access: yesActa Neuropathol
Lotsch C   +21 more
europepmc   +1 more source

Design and Characterization of Prodrugged Anti‐CTLA‐4 Antibodies

open access: yesChemBioChem, Accepted Article.
Therapeutic antibodies are widely used to treat diseases like cancer and inflammatory conditions by binding with high specificity to their molecular targets. Masking is a strategy to mitigate undesirable activity in non‐target tissues, improving safety and pharmacokinetic (PK) profiles by reducing target‐mediated drug disposition (TMDD). In this study,
Sayumi Yamazoe   +15 more
wiley   +1 more source

Micro-nano microbial fuel cell-driven bioelectrochemical tumor therapy. [PDF]

open access: yesNat Commun
Li R   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy